Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
551
PUT
DraftKings
DKNG
$9.23B
| $141M | 0.02% |
3,786,000
+768,100
| +25% | +$30.5M |
2020 Q1
19 quarters
|
|
552
Comcast
CMCSA
$76.5B
| $141M | 0.02% |
3,748,355
-2,949,149
| -44% | -$122M |
2023 Q1
7 quarters
|
|
553
PUT
Affirm
AFRM
$23.9B
| $140M | 0.02% |
2,304,500
-405,000
| -15% | -$22.5M |
2021 Q1
15 quarters
|
|
554
Caesars Entertainment
CZR
$6.04B
| $140M | 0.02% |
4,191,175
+761,536
| +22% | +$30.2M |
2018 Q2
26 quarters
|
|
555
CALL
Lennar Class A
LEN
$19.2B
| $140M | 0.02% |
1,059,755
+370,434
| +54% | +$60.2M |
2013 Q2
46 quarters
|
|
556
C.H. Robinson
CHRW
$18.4B
| $140M | 0.02% |
1,353,806
+148,866
| +12% | +$16M |
2017 Q4
28 quarters
|
|
557
CALL
Vertex Pharmaceuticals
VRTX
$128B
| $140M | 0.02% |
347,100
+137,600
| +66% | +$63.8M |
2013 Q2
46 quarters
|
|
558
PUT
3M
MMM
$83.5B
| $140M | 0.02% |
1,082,300
-149,400
| -12% | -$19.6M |
2013 Q2
46 quarters
|
|
559
American Tower
AMT
$75.6B
| $140M | 0.02% |
761,064
+612,723
| +413% | +$127M |
2013 Q2
46 quarters
|
|
560
Globant
GLOB
$1.52B
| $139M | 0.02% |
650,333
+647,432
| +22,318% | +$141M |
2022 Q4
8 quarters
|
|
561
CALL
GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF
NVDL
$3.95B
| $139M | 0.02% |
6,279,900
+525,300
| +9% | +$12.7M |
2023 Q3
5 quarters
|
|
562
Prologis
PLD
$123B
| $139M | 0.02% |
1,313,807
+1,064,960
| +428% | +$122M |
2020 Q4
16 quarters
|
|
563
CALL
Thermo Fisher Scientific
TMO
$242B
| $137M | 0.02% |
264,000
-47,300
| -15% | -$26M |
2013 Q2
46 quarters
|
|
564
PUT
Merck
MRK
$356B
| $137M | 0.02% |
1,378,500
| – | – |
2013 Q2
46 quarters
|
|
565
Regeneron Pharmaceuticals
REGN
$75.7B
| $137M | 0.02% |
192,346
+122,086
| +174% | +$102M |
2020 Q3
17 quarters
|
|
566
Amgen
AMGN
$218B
| $137M | 0.02% |
524,503
+516,699
| +6,621% | +$153M |
2024 Q1
3 quarters
|
|
567
PUT
Intuitive Surgical
ISRG
$138B
| $137M | 0.02% |
261,700
-99,400
| -28% | -$51.8M |
2013 Q2
46 quarters
|
|
568
MongoDB
MDB
$28.8B
| $137M | 0.02% |
586,320
+244,200
| +71% | +$69M |
2019 Q1
23 quarters
|
|
569
ServiceNow
NOW
$139B
| $136M | 0.02% |
642,360
+504,690
| +367% | +$102M |
2023 Q3
5 quarters
|
|
570
CALL
iShares Semiconductor ETF
SOXX
$50.2B
| $135M | 0.02% |
628,100
-139,100
| -18% | -$31M |
2017 Q1
31 quarters
|
|
571
RTX Corp
RTX
$249B
| $135M | 0.02% |
1,165,691
+1,056,905
| +972% | +$128M |
2013 Q2
46 quarters
|
|
572
CALL
Zillow
Z
$6.16B
| $135M | 0.02% |
1,819,900
+76,400
| +4% | +$5.46M |
2015 Q3
37 quarters
|
|
573
Danaher
DHR
$150B
| $135M | 0.02% |
586,909
-84,477
| -13% | -$20.8M |
2013 Q2
46 quarters
|
|
574
DT Midstream
DTM
$12.3B
| $135M | 0.02% |
1,353,329
+1,129,279
| +504% | +$108M |
2021 Q3
13 quarters
|
|
575
Evergy
EVRG
$18.3B
| $134M | 0.02% |
2,182,316
+813,377
| +59% | +$50.3M |
2022 Q1
11 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.